Transforming Critical Care: CytoSorbents’ Blood-Purification Programs Deliver Growing Revenues as DrugSorb-ATR Moves Toward a Mid-2026 FDA Review

Monday, December 15, 2025

11:00 AM – 12:00 PM ET

Jason Kolbert

Head of Research
D. Boral Capital

Dr. Phillip Chan

CEO
CytoSorbents

Peter J. Mariani

CFO
CytoSorbents

Watch Webinar